Intervention Targeting Substance Using Older Adults With HIV

Overview

The proposed study uses a randomized controlled experimental design to evaluate the efficacy of a brief intervention using spiritual self schema (3S+) counseling to simultaneously target HIV health outcomes, and substance use among alcohol and/or drug dependent HIV positive older adults (age 50+), relative to an attention control condition. Participants will be randomly assigned to receive either: (1) 12 sessions of 3S+ counseling, adapted for the present study to target both non-injection drug use, drinking, and HIV health; or (2) 12 sessions of education about HIV health and the associated with alcohol and drug use that will serve as an attention-control.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 2015

Interventions

  • Behavioral: Spiritual Self-Schema Therapy
    • The Spiritual Self Schema therapy (3S+) intervention will consist of a series of 12 one hour-long sessions delivered individually to participants over a four-month period. The 3S+ approach combines cognitive and behavioral therapy techniques with elements of non-theistic Buddhist philosophy to increase motivation for treatment adherence, alcohol and/or substance use reduction or abstinence and the prevention or reduction of HIV risk behaviors. 3S+ draws from self-regulation theory, self-schema theory, and self-discrepancy theory to assist participants in defining and perceiving their addict self, when their addict self is active, and its resulting negative affect state. 3S+ remediates the “addict” schema by proposing the construction of an alternate and competing schema: the “spiritual self.” This spiritual self schema is compatible with HIV self-care, alcohol and drug use reduction or abstinence, adherence to treatment, and a compassionate life.

Arms, Groups and Cohorts

  • Experimental: Intervention Condition
    • Twelve sessions of spiritual self schema counseling, adapted to target target medication adherence and substance use.
  • Active Comparator: Education Condition
    • Eight sessions of education with content designed to mirror the information covered in the intervention condition.

Clinical Trial Outcome Measures

Primary Measures

  • Adherence to HIV medication
    • Time Frame: every four months over the course of a year
    • Participants in the intervention condition will report greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison at the end of the intervention period (4 months). Those in the intervention condition will also maintain greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison condition at the three follow-up assessments (4, 8, and 12 months).
  • Substance use
    • Time Frame: every four months over the course of a year
    • Participants in the intervention condition will report greater reductions in self-reported days of substance use and severity of dependence than those in the education comparison at at the end of the intervention period (4 months). Those in the intervention condition will also maintain greater reductions in self-reported days of substance use than those in the education comparison condition at the three follow-up assessments (4, 8, and 12 months).

Secondary Measures

  • Mental Health/Quality of Life
    • Time Frame: every four months over the course of a year
    • Participants in the intervention condition will report greater increases in mental health measures (e.g, depression, anxiety) and quality of life measures (e.g., life satisfaction, loneliness, perceived stress).
  • Sexual Risk
    • Time Frame: every four months over the course of a year
    • Participants in the intervention condition will report greater reductions in high-risk sexual behavior compared to participants in the educational comparison condition.

Participating in This Clinical Trial

Inclusion Criteria

  • HIV+ (provide HIV medication bottle with name on it) – Age 50 or older (provide picture ID with DOB at baseline) – Report current alcohol/drug dependence (AUDIT score of 8 or DAST-10 score of 4 on screener; C-DIS at baseline) – On a prescribed HAART medication regimen and reports sub-optimal adherence (self-report missed at least 3 days in last 30 at 1 pill/day that is 90%) – Communicate with staff and complete a survey in English or Spanish (English only for the pilot) Exclusion Criteria:

  • Current intravenous drug use (self-report at screener and baseline) – Currently in a methadone drug treatment program (screener self-report) – Unstable, serious psychiatric symptoms (SCID-Psych at baseline) – Currently suicidal/homicidal (SCID-Psych at baseline) – Gross cognitive impairment (Mini-Mental at baseline) – Current enrollment in alcohol/drug treatment or HIV study (screener self-report)

Gender Eligibility: All

Minimum Age: 50 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hunter College of City University of New York
  • Collaborator
    • Fordham University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jeffrey T. Parsons, Professor – Hunter College of City University of New York
  • Overall Official(s)
    • Jeffrey T. Parsons, Ph.D., Principal Investigator, Hunter College, CUNY

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.